![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/07/02/2907131/0/en/Ipsen-expands-collaboration-and-license-agreement-for-development-of-Cabometyx-in-advanced-neuroendocrine-tumors-based-on-positive-CABINET-Phase-III-trial.html